Literature DB >> 23445912

Disuse induced by botulinum toxin affects the bone marrow expression profile of bone genes leading to a rapid bone loss.

H Marchand-Libouban1, M A Le Drévo, D Chappard.   

Abstract

OBJECTIVES: Molecular events occurring in the bone marrow microenvironment of an immobilized mouse limb after Botulinum toxin (BTX) injection haven't been characterized. BTX injection induces a localized disuse in which the tissue events have well been characterized.
METHODS: BTX injection was performed in the right quadriceps; saline injection in the left side was used as control. Mice were sacrificed at 0, 7, 14, 21 and 28 days; tibias were used for microCT analysis; bone marrow from femurs for RT-PCR analysis.
RESULTS: MicroCT revealed bone loss and microarchitectural damages on the immobilized side as from 7d; cortical area tended to be lower on the immobilized limb at 28d. Gene expression of formation factors was altered as from 7 days post-BTX: alkaline phosphatase, Tgfβ1, Lrp5, Sfrp2. Only Sfrp2 and Lrp5 were maintained altered until 28d. Expression of Dkk1 increased from 21d and represented a late inhibitor of formation. Gene expression of resorption markers increased as from 7d (Rankl, Tracp, Il1α, Il1β and Il6) and was maintained until 28d for Tracp and Il6.
CONCLUSION: A localized disuse induces rapid modifications in the bone marrow gene expression leading to bone loss due to an early decrease of formation associated with an increase in resorption.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23445912

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  8 in total

1.  Muscle paralysis induces bone marrow inflammation and predisposition to formation of giant osteoclasts.

Authors:  Brandon J Ausk; Leah E Worton; Kate S Smigiel; Ronald Y Kwon; Steven D Bain; Sundar Srinivasan; Edith M Gardiner; Ted S Gross
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-30       Impact factor: 4.249

Review 2.  Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse.

Authors:  T Bettis; B-J Kim; M W Hamrick
Journal:  Osteoporos Int       Date:  2018-05-18       Impact factor: 4.507

3.  Mechanical load increases in bone formation via a sclerostin-independent pathway.

Authors:  A Morse; M M McDonald; N H Kelly; K M Melville; A Schindeler; I Kramer; M Kneissel; M C H van der Meulen; D G Little
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

Review 4.  Botulinum Toxin A and Osteosarcopenia in Experimental Animals: A Scoping Review.

Authors:  Min Jia Tang; H Kerr Graham; Kelsey E Davidson
Journal:  Toxins (Basel)       Date:  2021-03-14       Impact factor: 4.546

5.  Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.

Authors:  G Mabilleau; A Mieczkowska; H Libouban; Y Simon; M Audran; D Chappard
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-03       Impact factor: 2.041

6.  Alterations in gene expression precede sarcopenia and osteopenia in botulinum toxin immobilized mice.

Authors:  J B Vegger; A Brüel; A F Dahlgaard; J S Thomsen
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-12-14       Impact factor: 2.041

7.  Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.

Authors:  Jens Bay Vegger; Annemarie Brüel; Jesper Skovhus Thomsen
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-06-01       Impact factor: 2.041

8.  Treatment With a Soluble Bone Morphogenetic Protein Type 1A Receptor (BMPR1A) Fusion Protein Increases Bone Mass and Bone Formation in Mice Subjected to Hindlimb Unloading.

Authors:  Frank C Ko; Miranda Van Vliet; Rachel Ellman; Daniel Grasso; Daniel J Brooks; Jordan M Spatz; Chrissy Conlon; J Ignacio Aguirre; Thomas J Wronski; Mary L Bouxsein
Journal:  JBMR Plus       Date:  2017-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.